USPTO serial 85651783
DAEWOONG
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRODY, DANIEL S
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DAEWOONG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sungnam-city Kyunggido, KR
Sungnam-city Kyunggido, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
MARK J. LISS LEYDIG, VOIT & MAYER, LTD.2 PRUDENTIAL PLAZA 180 N STETSON AVE STE 4900CHICAGO, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, acetaminophen, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; dietary and nutritional supplements; medicated skin lotions; bandages for skin wounds; vitamins; biological preparations for medical purposes for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; all-purpose disinfecting and deodorizing preparations; pharmaceutical preparations for use in cardiovascular treatment; diagnostic agents for medical purposes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations to prevent swelling in the legs; pharmaceutical preparations for treating respiratory diseases and asthma; pharmaceutical preparations for the treatment of erectile dysfunction; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; plant extracts adapted for use in the treatment of the central nervous system, diabetes, skin disorders, wounds, eye diseases and conditions, swelling in the legs, respiratory diseases, asthma, erectile dysfunction, cardiovascular conditions, heart rhythm disorders and infectious diseases; plant extracts adapted for use in chemotherapy; veterinary preparations for treatment of intestinal bacteria in mammals; veterinary preparations, namely, vaccines; sanitary preparations for medical use | ACTIVE | — |
| 035 | Pharmaceutical sales promotion for others; providing business information for pharmaceuticals; business management assistance on pharmaceuticals; market research; market study; advertising services; arranging of pharmaceutical sale, namely, procuring of contracts for the purchase and sale of pharmaceuticals, retail services by direct solicitation by sales agents in the field of pharmaceuticals; export-import agency; retail store services in the field of health supplements, retail services by direct solicitation by sales agents in the field of health supplements; retail store services in the field of cosmetics, retail services by direct solicitation by sales agents in the field of cosmetics; procurement services, namely, purchasing pharmaceuticals for others | ACTIVE | — |
| 044 | Medical clinics; pharmaceutical advice; preparation and dispensing of pharmaceuticals; technology services on selecting medicines, namely, interactive medical monitoring and alert services for reminding clients of medical information, namely, medicinal dosage, allergic sensitivity and prescription refills; providing medical information about medical equipment, devices and pharmaceutical preparations; clinical pathology services for the diagnosis and treatment of disease; medical assistance services; medical testing for diagnostic or treatment purposes; medical and health care, namely, ambulant medical care; cosmetic analysis; rental of medical equipment; rental of sanitary equipment, namely, clean chambers for sanitary purposes, urinals for sanitary fixtures, hand washing basins and bowls for sanitary installations and water pipes for sanitary installations; providing pharmacy advice; providing medical product information; health care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Daewoong Co., Ltd.
- Other trademarks owned by Daewoong Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named DAEWOONG
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 22, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 23, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2016 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 6, 2016 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 6, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 9, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2015 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 30, 2015 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 30, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 20, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 26, 2015 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 5, 2015 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 5, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 25, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 24, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 23, 2014 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 25, 2014 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 25, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 28, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 26, 2013 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 26, 2013 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 26, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 18, 2013 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 18, 2012 | NWAP | NEW APPLICATION ENTERED | — |